Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thank you for your cogent/sharp analysis
Quo Vadis MZEI?
That said about hospital air purification for MERS, there are still plenty of indications for AS technology. Consider that after 48 hours, MERS viral particles are still alive and well on plastic and steel surfaces, fabrics, etc, and that cannot be touched by air purifiers (Eurosurveillance, Vol. 18, Issue 38).
Any room(s) that have been occupied by MERS patients should receive AS treatment, as should operating suites.
I am sure the extensive Saudi family wants the best for their own. and that means a totally safe hospital environment.
And AS applies not only to MERS, which is currently expanding its reach demographically and geographically. Just about all experts agree that Ebola and bird flu will likely make strong comebacks, but nobody knows when.
I believe, in the relatively short term, that the Family of Coronaviruses (MERS, SARS) will provide the opportunity for Medizone to prove itself.
That's true
Thank you, I will do so, and to some contacts in the Middle East, including editors of medical and health journals.
Hospitals as incubators of MERS
http://www.cidrap.umn.edu/news-perspective/2015/02/mers-persists-who-cites-hospital-linked-clusters
I've been in touch with Geneva on another matter and I inquired..
The key to greater global awareness and speedier acceptance of the AS system is the WHO. The WHO also has tight liaison with the EPA.
Yes, for the healing of infected wounds. Medizone has a related patent.
Ozone levels set by EPA, as far as I know, are concerned with chronic ambient workplace and other environmental levels. AS incorporates ozone destructors so that, rapidly, there is no ambient ozone left.
The Ebola organism is lipid enveloped and therefore all the more susceptible to ozone/hydrogen peroxide inactivation.
My pleasure. Here is the link:
http://www.google.com/patents/US6073627
The US granted Medizone patent for wound resolution "Method for the application of ozone/oxygen for the treatment of external pathogenic conditions" (09/126.504) is not flawed in any way. It has about 6 years of life to go. Human need for this technology would include the thousands of veterans with poorly healing war wounds, and those who fight ongoing battles with non-healing diabetic and vascular ulcers that too often end up with limb amputations.
Hospital fungal invaders. As all fungi, this one can be easily inactivated with ozone.
http://www.nytimes.com/2014/04/29/us/a-deadly-fungus-and-questions-at-a-hospital.html?hp&_r=0
Update on the new MERS epidemic:
http://guardianlv.com/2014/04/mers-cases-appear-throughout-middle-east-is-world-facing-a-new-epidemic/
Just to point out that ozone would have no problem wiping out Ebola, an important consideration in today's epidemic.
Medizone has a granted patent on this process.
If Canadian hospitals can now incorporate Asepticsure technology and thus promote the fact that they are pathogen-free, patients the world over will gravitate there. I base this opinion on the ever increasing numerous enquiries that convey deep anxieties about the perceived dangers associated with all manner of medical/surgical interventions currently performed in US hospitals. Once Canada leads the way, other Tier One countries will have to follow.
Janssen Pharmaceuticals has initiated a recall of one of its products, RISPERIDAL CONSTA, an injectable anti-psychotic agent due to a "sterility failure." A mold "commonly found in the environment" is the cause of this recall.
For those investors who have called with questions about the science of medical ozone:
"Ozone, a physiological gas, is created in vivo"
http://www.ozoneinmedicine.com/articles_vivo.html
ozoneinmedicine.com
The spreading of H7N9 may have something to do with this.
There are numerous health-related press release networks that would be eager to telegraph the Medizone science, all free or near free of charge, reaching massive audiences with myriad scientific and other interests.
The art of it is basically to write texts edited to respect the readership of each network, and once published they simply go all over the globe.
It all would work to avoid the downs following the surges, keeping steady on an upward trajectory.
I would not sweat the US patent issue at this time. As one who has filed many patents over many years, I can say that “final rejection” does not mean the demise of a patent. First of all, any patent will propose a series of claims, sometimes dozens – which ones have been granted, which ones rejected? And if rejected, there begins a long process of modification, or tweaking of the claims in question, then negotiations with the examiner, and if rejection persist, there are layers of authority beyond that examiner and layers of appeal process. Sometimes, we are talking years of back and forth. Required are tenacity, patience, fortitude, and scientific acumen in showing how the claims are unique, or creatively finding ways to make the claims stand out as clearly different from what is called “prior art.” Meanwhile, the “patent pending” appellation continues to be valid and in force, that is important to maintain.
The FDA/EPA approval, probably close at hand, will allow much greater movement forward.
New York University Langone Medical Center is currently shut down because its main, and its backup power supplies are totally inactivated by the storm. In this vast complex, all operating suites and treatment rooms are now dark and abandoned.
This is one scenario where sterilization technologies such as AsepticSure could be extremely useful, to the task of returning these hospital facilities to proper operation.
Hyperbaric treatment of wounds requires a pressure chamber. The whole patient is confined and it is not possible to introduce ozone because the patient would breathe it in. The Medizone method on the other hand, requires only a plastic envelope encasing the wound, at normal atmospheric pressure. The ozone generator itself is small and easily portable, thus making home care very feasible.
One note on the FDA: since this is an external method, approval for a study would be much shorter than, for instance, any method involving parenteral/injectable means.
Oxygen/ozone wound healing is used in Germany, Russia, Italy, France, Switzerland, Brazil, Egypt (U. of Cairo), among others. Medizone has the patent in the US!
A US-granted patent, such as the wound-healing patent, adds great value to Medizone fund of intellectual properties.
The beauty of ozone in wound healing is especially relevant is cases where infection is present. Infection is by far the principal reason why wounds fester and fail to heal. All manner of bacteria and fungi colonize wounds, belonging to many different families and species. In one study, for example, 20 different bacterial and fungal species were found to grow on infected diabetic skin ulcers, and while topical and systemic antibiotics can only address a few of them (and can have side effects), ozone inactivates them all!
Wound healing failures also consistently implicate toxins. Bacteria and fungi create toxins to counter healthy tissues’ attempts to heal, much like mustard gas was used in wars. Antibiotics do not directly neutralize toxins, ozone on the other hand, directly destroys them via oxidation.
With some 100,000 lower leg amputations due to diabetic skin and tissue infections in the US per year, Medizone wound healing technology could fill a great human need.
Plan B could make use of Medizone's only granted patent on accelerated wound healing with externally applied oxygen/ozone mixtures. we're talking about diabetic skin ulcers, vascular skin ulcers, burns, poorly healing wounds of all kinds, war wounds. 15% of the some 25 million US diabetics develop serious skin ulcerations, and 15% of those patients eventually require lower leg amputations. Wound healing products command a 5 billion market in the US alone, and 22 billion global. The FDA has already approved topical oxygen for wound healing, all Medizone would need is a cooperative wound healing project with a reputable academic center to add miniscule concentrations of ozone to the oxygen to prove the superior healing power of the mix. This has already been well documented, but never in a Tier One country.
Information on the therapeutic external uses of ozone/oxygen gas mixtures can be found on:
ozoneinmedicine.com
The recent decision of the World Health Organization (WHO) to publish the science of mutating the bird flu H5N1 virus will spark ever greater demand by governmental agencies, defense agencies, and health care facilities to engage Medizone's technology.